Concepedia

Célia Jacoberger-Foissac

CJ

Statistics

Publications

8

Citations

557

H-Index

8

Active since

2019

Affiliations

QIMR Berghofer Medical Research Institute(Current)

Centre Hospitalier de l’Université de Montréal

Beth Israel Deaconess Medical Center

Université de Montréal

Rapt Therapeutics (United States)

Célia Jacoberger-Foissac is an author at QIMR Berghofer Medical Research Institute specializing in immunology, oncology, and cancer immunotherapy.

ORCID

Publications per year

2019–2023

8

Publications

8

Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity

Xian-Yang Li, Achim K. Moesta, Christos Xiao et al. · Cancer Discovery · 2019 · 268 citations · Full text

, , +17

Control of Metastases via Myeloid CD39 and NK Cell Effector Function

Juming Yan, Xian-Yang Li, Amelia Roman Aguilera et al. · Cancer Immunology Research · 2020 · 81 citations

, , +17

CD73 Inhibits cGAS–STING and Cooperates with CD39 to Promote Pancreatic Cancer

Célia Jacoberger-Foissac, Isabelle Cousineau, Yacine Barèche et al. · Cancer Immunology Research · 2022 · 73 citations · Full text

, , +17

Addition of interleukin-2 overcomes resistance to neoadjuvant CTLA4 and PD1 blockade in ex vivo patient tumors

Paulien Kaptein, Célia Jacoberger-Foissac, Petros Dimitriadis et al. · Science Translational Medicine · 2022 · 52 citations · Full text

, , +17

Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma

Bertrand Allard, Célia Jacoberger-Foissac, Isabelle Cousineau et al. · Cell Reports Medicine · 2023 · 27 citations · Full text

, , +17

1–5 of 8